Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients by Peters, Charlotte P., Eshuis, Emma J., Toxopeüs, Florien M., Hellemons, Merel E., Jansen, Jeroen M., D'Haens, Geert R.A.M., Fockens, Paul, Stokkers, Pieter C.F., Tuynman, Hans A.R.E., van Bodegraven, Adriaan A., Ponsioen, Cyriel Y.

Get full text